Seitz DE - Search Results

1

Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases.

Fossella FV, Lippman SM, Seitz DE, Alberts DS, Taylor CW, Wiltshaw E, Hardy J, O'Brien M, Haynes TR, Wolen RL. Fossella FV, et al. Among authors: seitz de. Invest New Drugs. 1991 Nov;9(4):357-9. doi: 10.1007/BF00183581. Invest New Drugs. 1991. PMID: 1804813 Clinical Trial. No abstract available.

2

Phase II study of sulofenur (LY 186641). A novel antineoplastic agent in advanced non-small cell lung cancer.

Munshi NC, Seitz DE, Fossella F, Lippman SM, Einhorn LH. Munshi NC, et al. Among authors: seitz de. Invest New Drugs. 1993 Feb;11(1):87-90. doi: 10.1007/BF00873919. Invest New Drugs. 1993. PMID: 8394298 Clinical Trial.

3

Antitumor activity and clinical pharmacology of sulofenur in ovarian cancer.

Taylor CW, Alberts DS, Peng YM, McCloskey TM, Matzner M, Roe DJ, Plezia PM, Grindey GB, Hamilton M, Seitz D. Taylor CW, et al. J Natl Cancer Inst. 1992 Dec 2;84(23):1798-802. doi: 10.1093/jnci/84.23.1798. J Natl Cancer Inst. 1992. PMID: 1433369 Clinical Trial.

4

Phase II evaluation of the sulfonylurea LY186,641 in men with hormone independent metastatic prostate cancer.

Wilding G, Grindey G, Munshi N, Seitz D, Einhorn L. Wilding G, et al. Invest New Drugs. 1993 May-Aug;11(2-3):203-5. doi: 10.1007/BF00874156. Invest New Drugs. 1993. PMID: 8262732 Clinical Trial. No abstract available.

5

Phase II study of gemcitabine plus docetaxel in advanced pancreatic cancer: a Hoosier Oncology Group study.

Schneider BP, Ganjoo KN, Seitz DE, Picus J, Fata F, Stoner C, Calley C, Loehrer PJ. Schneider BP, et al. Among authors: seitz de. Oncology. 2003;65(3):218-23. doi: 10.1159/000074474. Oncology. 2003. PMID: 14657595 Clinical Trial.

6

Chemotherapeutic approaches to the treatment of testicular cancer.

Seitz DE, Loehrer PJ Sr, Williams SD, Einhorn LH. Seitz DE, et al. Semin Urol. 1988 Aug;6(3):238-45. Semin Urol. 1988. PMID: 2469118 No abstract available.

7

A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer.

Pan CX, Loehrer P, Seitz D, Helft P, Juliar B, Ansari R, Pletcher W, Vinson J, Cheng L, Sweeney C. Pan CX, et al. Oncology. 2005;69(1):63-70. doi: 10.1159/000087302. Epub 2005 Aug 2. Oncology. 2005. PMID: 16088234 Clinical Trial.

8

Phase I trial of carboplatin and paclitaxel with escalating doses of oral topotecan in patients with solid tumors.

Hanna N, Sweeney C, Fife K, Dropcho S, Seitz DE. Hanna N, et al. Among authors: seitz de. Am J Clin Oncol. 2003 Apr;26(2):200-2. doi: 10.1097/00000421-200304000-00021. Am J Clin Oncol. 2003. PMID: 12714897 Clinical Trial.

9

Clinical oncology and chemical thermodynamics.

Seitz DE, Pearce HL. Seitz DE, et al. Cancer Invest. 1990;8(2):233-5. doi: 10.3109/07357909009017569. Cancer Invest. 1990. PMID: 2400939

10

Oncology drug discovery and clinical trial testing: who's listening?

Seitz DE. Seitz DE. Cancer Invest. 1992;10(4):327-9. doi: 10.3109/07357909209032758. Cancer Invest. 1992. PMID: 1628229 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters